Neoadjuvant Therapy Prior to Prostatectomy: Is the Glass Half Full?
- 1 June 2023
- journal article
- editorial
- Published by Elsevier BV in European Urology
- Vol. 83 (6), 519-520
- https://doi.org/10.1016/j.eururo.2023.01.021
Abstract
No abstract availableFunding Information
- Janssen Pharmaceuticals
This publication has 15 references indexed in Scilit:
- Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic AlterationsCancer Research, 2018
- Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyClinical Cancer Research, 2017
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate CancerThe New England Journal of Medicine, 2017
- Neoadjuvant Enzalutamide Prior to ProstatectomyClinical Cancer Research, 2017
- A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical ProstatectomyClinical Cancer Research, 2017
- Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant StudyJournal of Clinical Oncology, 2014
- Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized TrialJournal of Clinical Oncology, 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerThe New England Journal of Medicine, 2004
- Cell proliferation and apoptosis in prostate tumors and adjacent non‐malignant prostate tissue in patients at different time‐points after castration treatmentThe Prostate, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003